Posts

Showing posts with the label The findings could add momentum for F.D.A. authorization of the pediatric dose

F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11

U.S.

F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11

U.S.